POTASSIUM PHOSPHATE INJ 3MMP/ML SOLUTION Canada - English - Health Canada

potassium phosphate inj 3mmp/ml solution

hospira healthcare ulc - potassium phosphate monobasic; potassium phosphate dibasic - solution - 224mg; 236mg - potassium phosphate monobasic 224mg; potassium phosphate dibasic 236mg - replacement preparations

Sabax Potassium Phosphate solution for injection after dilution Namibia - English - Namibia Medicines Regulatory Council

sabax potassium phosphate solution for injection after dilution

adcock-ingram critical care - monobasic potassium phosphate 1.09 g; ; potassium phosphate dibasic 1.05 g - injectable solution - in 10ml; monobasic potassium phosphate 1.09 g; ; potassium phosphate dibasic 1.05 g

MONOBASIC SODIUM PHOSPHATE AND DIBASIC SODIUM PHOSPHATE tablet United States - English - NLM (National Library of Medicine)

monobasic sodium phosphate and dibasic sodium phosphate tablet

novel laboratories, inc. - sodium phosphate, monobasic, monohydrate (unii: 593yog76rn) (sodium cation - unii:lyr4m0nh37), sodium phosphate, dibasic anhydrous (unii: 22ado53m6f) (sodium cation - unii:lyr4m0nh37) - sodium phosphate, monobasic, monohydrate 1.105 g - monobasic sodium phosphate and dibasic sodium phosphate tablets are indicated for cleansing of the colon as a preparation for colonoscopy in adults 18 years of age or older. monobasic sodium phosphate and dibasic sodium phosphate tablets are contraindicated in patients with biopsy-proven acute phosphate nephropathy. monobasic sodium phosphate and dibasic sodium phosphate tablets are contraindicated in patients with a known allergy or hypersensitivity to sodium phosphate salts or any of its ingredients. laxatives and purgatives (including monobasic sodium phosphate and dibasic sodium phosphate tablets) have the potential for abuse by bulimia nervosa patients who frequently have binge eating and vomiting.

K PHOS ORIGINAL- potassium phosphate, monobasic tablet, soluble United States - English - NLM (National Library of Medicine)

k phos original- potassium phosphate, monobasic tablet, soluble

carilion materials management - potassium phosphate, monobasic (unii: 4j9fj0hl51) (phosphate ion - unii:nk08v8k8hr, potassium cation - unii:295o53k152) - potassium phosphate, monobasic 500 mg - this product is contraindicated in patients with infected phosphate stones; in patients with severely impaired renal function (less than 30% of normal) and in the presence of hyperphosphatemia and hyperkalemia.

K PHOS ORIGINAL- potassium phosphate, monobasic tablet, soluble United States - English - NLM (National Library of Medicine)

k phos original- potassium phosphate, monobasic tablet, soluble

beach products, inc. - potassium phosphate, monobasic (unii: 4j9fj0hl51) (phosphate ion - unii:nk08v8k8hr, potassium cation - unii:295o53k152) - potassium phosphate, monobasic 500 mg - this product is contraindicated in patients with infected phosphate stones; in patients with severely impaired renal function (less than 30% of normal) and in the presence of hyperphosphatemia and hyperkalemia.

K-PHOS NO. 2- potassium phosphate, monobasic and sodium phosphate, monobasic, anhydrous tablet, coated United States - English - NLM (National Library of Medicine)

k-phos no. 2- potassium phosphate, monobasic and sodium phosphate, monobasic, anhydrous tablet, coated

beach products, inc. - potassium phosphate, monobasic (unii: 4j9fj0hl51) (phosphate ion - unii:nk08v8k8hr, potassium cation - unii:295o53k152), sodium phosphate, monobasic, anhydrous (unii: kh7i04hpuu) (phosphate ion - unii:nk08v8k8hr, sodium cation - unii:lyr4m0nh37) - potassium phosphate, monobasic 305 mg - this product is contraindicated in patients with infected phosphate stones, in patients with severely impaired renal function (less than 30% of normal) and in the presence of hyperphosphatemia.

Potassium Phosphate Concentrate (REM) New Zealand - English - Medsafe (Medicines Safety Authority)

potassium phosphate concentrate (rem)

paragon care group new zealand limited - dibasic potassium phosphate 2 meq/ml; monobasic potassium phosphate 2 meq/ml - solution for infusion - 2 meq/ml - active: dibasic potassium phosphate 2 meq/ml monobasic potassium phosphate 2 meq/ml

POTASSIUM PHOSPHATE MONOBASIC INJECTION SOLUTION Canada - English - Health Canada

potassium phosphate monobasic injection solution

sandoz canada incorporated - potassium phosphate monobasic - solution - 176mg - potassium phosphate monobasic 176mg - replacement preparations

Potassium Phosphate 1mmol/ml + 0.6mmol/ml Concentrate for Solution for Infusion Ireland - English - HPRA (Health Products Regulatory Authority)

potassium phosphate 1mmol/ml + 0.6mmol/ml concentrate for solution for infusion

b. braun medical limited - dipotassium phosphate ; potassium dihydrogen phosphate - concentrate for solution for infusion - 1mmol/ml + 0.6 millimole(s)/millilitre - electrolyte solutions; potassium phosphate, incl. combinations with other potassium salts

PHEBRA POTASSIUM PHOSPHATE CONCENTRATED Injection Australia - English - Department of Health (Therapeutic Goods Administration)

phebra potassium phosphate concentrated injection

phebra pty ltd - monobasic potassium phosphate, quantity: 109.33 mg/ml; dibasic potassium phosphate, quantity: 105.33 mg/ml - injection, intravenous infusion - excipient ingredients: water for injections - indications as at 01 january 1991 : treatment of severe hypophosphataemia (serum levels <0.3mmol/l) and other degrees of hypophosphataemia when oral therapy is not possible. lowering the ph of urine. the treatment of potassium depletion in patients with hypokalemia. iv administration is indicated when the patient is unable to take potassium orally or if hypokalemia is severe.